Cargando…
Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma
BACKGROUND: Definitive chemoradiation (dCRT) is considered curative intent treatment for patients with inoperable or irresectable esophageal cancer. Acute toxicity data focussing on dCRT are lacking. METHODS: A retrospective analysis of patients treated with dCRT consisting of 6 cycles of paclitaxel...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922650/ https://www.ncbi.nlm.nih.gov/pubmed/24485047 http://dx.doi.org/10.1186/1471-2407-14-56 |
_version_ | 1782303478594404352 |
---|---|
author | Haj Mohammad, Nadia Hulshof, Maarten CCM Bergman, Jacques JGHM Geijsen, Debby Wilmink, Johanna W van Berge Henegouwen, Mark I van Laarhoven, Hanneke WM |
author_facet | Haj Mohammad, Nadia Hulshof, Maarten CCM Bergman, Jacques JGHM Geijsen, Debby Wilmink, Johanna W van Berge Henegouwen, Mark I van Laarhoven, Hanneke WM |
author_sort | Haj Mohammad, Nadia |
collection | PubMed |
description | BACKGROUND: Definitive chemoradiation (dCRT) is considered curative intent treatment for patients with inoperable or irresectable esophageal cancer. Acute toxicity data focussing on dCRT are lacking. METHODS: A retrospective analysis of patients treated with dCRT consisting of 6 cycles of paclitaxel 50 mg/m2 and carboplatin AUC2 concomitant with radiotherapy (50.4 Gy\1.8Gy) from 2006 through 2011 at a single tertiary center was performed. Toxicity, hospital admissions and survival were analysed. RESULTS: 127 patients were treated with definitive chemoradiation. 33 patients were medically inoperable, 94 patients were irresectable, Despite of a significantly smaller tumor length in inoperable patients grade ≥3 toxicity was significantly recorded more often in the inoperable patients (44%) than in irresectable patients (20%) (p < 0.05) Hospital admission occurred more often in the inoperable patients (39%) than in the irresectable patients (22%) (p < 0.05) Median number of cycles of chemotherapy was five for inoperable patients (p = 0.01), while six cycles could be administered to patients with irresectable disease. Recurrence and survival were not significantly different. The odds ratio for developing toxicity ≥ grade 3 was 2.6 (95% CI 1.0-6.4 p < 0.05) for being an inoperable patient and 1.2 (95% CI 1.0-1.4 p = 0.02) per 10 extra micromol/l creatinine. CONCLUSIONS: Our data show that acute toxicity of definitive chemoradiation is worse in patients with medically inoperable esophageal carcinoma compared to patients with irresectable esophageal cancer and mainly occurs in the 5th cycle of treatment. Improvement of supportive care should be undertaken in this more fragile group. |
format | Online Article Text |
id | pubmed-3922650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39226502014-02-13 Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma Haj Mohammad, Nadia Hulshof, Maarten CCM Bergman, Jacques JGHM Geijsen, Debby Wilmink, Johanna W van Berge Henegouwen, Mark I van Laarhoven, Hanneke WM BMC Cancer Research Article BACKGROUND: Definitive chemoradiation (dCRT) is considered curative intent treatment for patients with inoperable or irresectable esophageal cancer. Acute toxicity data focussing on dCRT are lacking. METHODS: A retrospective analysis of patients treated with dCRT consisting of 6 cycles of paclitaxel 50 mg/m2 and carboplatin AUC2 concomitant with radiotherapy (50.4 Gy\1.8Gy) from 2006 through 2011 at a single tertiary center was performed. Toxicity, hospital admissions and survival were analysed. RESULTS: 127 patients were treated with definitive chemoradiation. 33 patients were medically inoperable, 94 patients were irresectable, Despite of a significantly smaller tumor length in inoperable patients grade ≥3 toxicity was significantly recorded more often in the inoperable patients (44%) than in irresectable patients (20%) (p < 0.05) Hospital admission occurred more often in the inoperable patients (39%) than in the irresectable patients (22%) (p < 0.05) Median number of cycles of chemotherapy was five for inoperable patients (p = 0.01), while six cycles could be administered to patients with irresectable disease. Recurrence and survival were not significantly different. The odds ratio for developing toxicity ≥ grade 3 was 2.6 (95% CI 1.0-6.4 p < 0.05) for being an inoperable patient and 1.2 (95% CI 1.0-1.4 p = 0.02) per 10 extra micromol/l creatinine. CONCLUSIONS: Our data show that acute toxicity of definitive chemoradiation is worse in patients with medically inoperable esophageal carcinoma compared to patients with irresectable esophageal cancer and mainly occurs in the 5th cycle of treatment. Improvement of supportive care should be undertaken in this more fragile group. BioMed Central 2014-01-31 /pmc/articles/PMC3922650/ /pubmed/24485047 http://dx.doi.org/10.1186/1471-2407-14-56 Text en Copyright © 2014 Haj Mohammad et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Article Haj Mohammad, Nadia Hulshof, Maarten CCM Bergman, Jacques JGHM Geijsen, Debby Wilmink, Johanna W van Berge Henegouwen, Mark I van Laarhoven, Hanneke WM Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma |
title | Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma |
title_full | Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma |
title_fullStr | Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma |
title_full_unstemmed | Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma |
title_short | Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma |
title_sort | acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922650/ https://www.ncbi.nlm.nih.gov/pubmed/24485047 http://dx.doi.org/10.1186/1471-2407-14-56 |
work_keys_str_mv | AT hajmohammadnadia acutetoxicityofdefinitivechemoradiationinpatientswithinoperableorirresectableesophagealcarcinoma AT hulshofmaartenccm acutetoxicityofdefinitivechemoradiationinpatientswithinoperableorirresectableesophagealcarcinoma AT bergmanjacquesjghm acutetoxicityofdefinitivechemoradiationinpatientswithinoperableorirresectableesophagealcarcinoma AT geijsendebby acutetoxicityofdefinitivechemoradiationinpatientswithinoperableorirresectableesophagealcarcinoma AT wilminkjohannaw acutetoxicityofdefinitivechemoradiationinpatientswithinoperableorirresectableesophagealcarcinoma AT vanbergehenegouwenmarki acutetoxicityofdefinitivechemoradiationinpatientswithinoperableorirresectableesophagealcarcinoma AT vanlaarhovenhannekewm acutetoxicityofdefinitivechemoradiationinpatientswithinoperableorirresectableesophagealcarcinoma |